natgillin/translations-raw huggingface dataset:
Although no increased incidence of adverse events was observed in these patients, when sildenafil is administered concomitantly with CYP3A4 inhibitors, a starting dose of 25 mg should be considered. 
Čeprav pri teh bolnikih niso ugotovili večje pogostnosti neželenih učinkov, je pri sočasni uporabi z zaviralci CYP3A4 priporočljivo uporabiti začetni odmerek 25 mg.
Sildenafil Actavis contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors. 
Zdravilo Sildenafil Actavis vsebuje zdravilno učinkovino sildenafil, ki sodi med zdravila, ki jih imenujemo zaviralci fosfodiesteraze tipa 5 (PDE5).
Certain patients have experienced these symptoms when taking sildenafil with alpha-blockers. 
Nekaterim bolnikom so se takšni simptomi pojavili med jemanjem sildenafila in antagonistov adrenergičnih receptorjev alfa.
- The active substance is sildenafil. 
- Zdravilna učinkovina je sildenafil.
Cimetidine (800 mg), a cytochrome P450 inhibitor and non-specific CYP3A4 inhibitor, caused a 56% increase in plasma sildenafil concentrations when co-administered with sildenafil (50 mg) to healthy volunteers. 
Cimetidin (800 mg), zaviralec citokroma P450 in nespecifičen zaviralec CYP3A4, je ob sočasni uporabi s sildenafilom (50 mg) pri zdravih prostovoljcih povzročil 56% povečanje koncentracije sildenafila v plazmi.
- If you are taking medicines called nitrates, as the combination may lead to a dangerous fall in your blood pressure. 
- če jemljete zdravila, ki se imenujejo nitrati, ker lahko sočasno jemanje vodi v nevaren padec vašega krvnega tlaka.
The Sildenafil Actavis tablet contains lactose monohydrate. 
Tablete Sildenafil Actavis vsebujejo laktozo monohidrat.
After oral dosing of sildenafil AUC and Cmax increase in proportion with dose over the recommended dose range (25-100 mg). 
Po peroralni uporabi sildenafila se AUC in Cmaks v priporočenem razponu odmerkov (od 25 do 100 mg) povečujeta sorazmerno z odmerkom.
Sildenafil Actavis contains lactose 
Zdravilo Sildenafil Actavis vsebuje laktozo
In a specific interaction study, where sildenafil (100 mg) was co-administered with amlodipine in hypertensive patients, there was an additional reduction on supine systolic blood pressure of 8 mmHg. 
V specifični interakcijski študiji, v kateri so bolniki z zvišanim krvnim tlakom uporabljali sildenafil (100 mg) sočasno z amlodipinom, se je sistolični krvni tlak leže dodatno znižal za 8 mmHg, diastolični krvni tlak leže pa za 7 mmHg.
- Chest pains - this occurs uncommonly If this occurs during or after intercourse Get in a semi-sitting position and try to relax. 
· Če imate bolečine v prsih - to se zgodi občasno Če se to zgodi med ali po spolnem odnosu se namestite v pol sedeč položaj in se poskusite sprostiti za ublažitev bolečin v prsih ne uporabljajte nitratov.
In addition, initiation of sildenafil at a dose of 25 mg should be considered (see sections 4.4 and 4.5). 
Poleg tega pride pri takšnih bolnikih v poštev uvedba sildenafila v odmerku 25 mg (glejte poglavji 4.4 in 4.5).
How to store Sildenafil Actavis Contents of the pack and other information 
Shranjevanje zdravila Sildenafil Actavis Vsebina pakiranja in dodatne informacije
Common (³ 1/100 and 
Pogosti (³ 1/100 in
Talk to your doctor, pharmacist or nurse before taking Sildenafil Actavis - If you have sickle cell anaemia (an abnormality of red blood cells), leukaemia (cancer of blood cells), multiple myeloma (cancer of bone marrow). 
Pred začetkom jemanja zdravila Sildenafil Actavis se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro: - če imate srpastocelično anemijo (nepravilnost rdečih krvnih celic), levkemijo (raka krvnih celic)
Lactose monohydrate Microcrystalline cellulose Povidone K29-32 
Jedro tablete: laktoza monohidrat mikrokristalna celuloza povidon K29-32 premreženi natrijev karmelozat magnezijev stearat
This metabolite has a phosphodiesterase selectivity profile similar to sildenafil and an in vitro potency for PDE5 approximately 50% that of the parent drug. 
Selektivnost tega presnovka za fosfodiesteraze je podobna selektivnosti sildenafila, njegov vpliv na PDE5 pa je in vitro približno 50% vpliva matičnega zdravila.
Pooling of the following classes of antihypertensive medication: diuretics, beta-blockers, ACE inhibitors, angiotensin II antagonists, antihypertensive medicinal products (vasodilator and centrally-acting), adrenergic neurone blockers, calcium channel blockers and alpha-adrenoceptor blockers, showed no difference in the side effect profile in patients taking sildenafil compared to placebo treatment. 
Pri bolnikih, ki so hkrati s sildenafilom jemali zdravila iz naslednjih skupin antihipertenzivov: diuretike, antagoniste adrenergičnih receptorjev beta, zaviralce ACE, antagoniste angiotenzina II, antihipertenzivna zdravila (vazodilatatorje in centralno delujoča), zaviralce adrenergičnih nevronov, zaviralce kalcijevih kanalčkov in antagoniste adrenergičnih receptorjev alfa, se profil neželenih učinkov ni razlikoval od profila pri bolnikih, ki so dobivali placebo.
What you need to know before you take Sildenafil Actavis Do not take Sildenafil Actavis - If you are allergic to sildenafil or any of the other ingredients of this medicine (listed in section 
Ne jemljite zdravila Sildenafil Actavis - če ste alergični na sildenafil ali katerokoli sestavino tega zdravila (navedeno v poglavju 6).
Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood. 
Posledica je povečanje koncentracije cikličnega gvanozinmonofosfata (cGMP), to pa povzroči sprostitev gladkih mišic v corpus cavernosum in omogoči dotok krvi.
In a study of healthy male volunteers, co-administration of the endothelin antagonist, bosentan, (an inducer of CYP3A4 [moderate], CYP2C9 and possibly of CYP2C19) at steady state (125 mg twice a day) with sildenafil at steady state (80 mg three times a day) resulted in 62.6% and 55.4% decrease in sildenafil AUC and Cmax, respectively. 
V študiji pri zdravih moških prostovoljcih, ki so sočasno jemali antagonist endotelina, bosentan, (induktor CYP3A4 (zmeren), CYP2C9 in morda CYP2C19) v stanju dinamičnega ravnotežja (125 mg dvakrat na dan) in sildenafil v stanju dinamičnega ravnotežja (80 mg trikrat na dan) je povzročilo 62,6% in 55,4% zmanjšanje AUC sildenafila in Cmax.
If Sildenafil Actavis is taken with food, the onset of activity may be delayed compared to the fasted state (see section 5.2). 
Če je zdravilo Sildenafil Actavis zaužito s hrano, lahko začne delovati pozneje, kot če je zaužito na prazen želodec (glejte poglavje 5.2).
There is a 10-fold selectivity over PDE6 which is involved in the phototransduction pathway in the retina. 
Za PDE5 je 10-krat bolj selektiven kot za PDE6, ki sodeluje v fototransdukcijski poti v mrežnici.
If you take more Sildenafil Actavis than you should You may experience an increase in side effects and their severity. 
Če ste vzeli večji odmerek zdravila Sildenafil Actavis, kot bi smeli Pojavijo se lahko bolj številni in bolj izraziti neželeni učinki.
No significant interactions were shown when sildenafil (50 mg) was co-administered with tolbutamide (250 mg) or warfarin (40 mg), both of which are metabolised by CYP2C9. 
Med sočasno uporabo sildenafila (50 mg) in tolbutamida (250 mg) ali varfarina (40 mg), ki se presnavljata s CYP2C9, ni bilo pomembnih medsebojnih delovanj.
What Sildenafil Actavis contains - The active substance is sildenafil. 
Kaj vsebuje zdravilo Sildenafil Actavis - Zdravilna učinkovina je sildenafil.
Sildenafil has no effect on visual acuity or contrast sensitivity. 
Sildenafil ne vpliva na ostrino vida ali razločevanje kontrastov.
Co-administration of sildenafil with ritonavir is not advised (see section 4.5). 
Sočasna uporaba sildenafila z ritonavirjem ni priporočljiva (glejte poglavje 4.5).
Caution is advised when sildenafil is administered to patients taking an alpha-blocker, as the co-administration may lead to symptomatic hypotension in a few susceptible individuals (see section 4.5). 
Previdnost je potrebna med uporabo sildenafila pri bolnikih, ki jemljejo antagoniste adrenergičnih receptorjev alfa, ker lahko sočasna uporaba pri maloštevilnih občutljivih posameznikih povzroči simptomatsko hipotenzijo (glejte poglavje 4.5).
How to take Sildenafil Actavis 
Kako jemati zdravilo sildenafil actavis
Rare (³ 1/10000 and 
Redki (³ 1/10000 in <1/1000)
Non-clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, and toxicity to reproduction and development. 
Predklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih se odmerkih, genotoksičnosti, kancerogenega potenciala in vpliva na sposobnost razmnoževanja in razvoja ne kažejo posebnega tveganja za človeka.
- If you are using any of the medicines known as nitric oxide donors such as amyl nitrite (“poppers”), as the combination may also lead to a dangerous fall in your blood pressure. 
- če jemljete zdravila, ki so znana kot dajalci dušikovega oksida, kakršen je amilnitrit (“poppers“ - nelegalno spolno poživilo), ker lahko sočasno jemanje povzroči nevaren padec vašega krvnega tlaka.
The most commonly reported adverse reactions in clinical studies among sildenafil treated patients were headache, flushing, dyspepsia, nasal congestion, dizziness, nausea, hot flush, visual disturbance, cyanopsia and vision blurred. 
Pri bolnikih, ki so v kliničnih študijah jemali sildenafil, so najpogosteje zabeležili naslednje neželene učinke: glavobol, zardevanje, dispepsijo, zamašenost nosu, omotico, navzeo, vročinske oblive, motnjo vida, cianopsijo in zamegljen vid.
Uncommon (³ 1/1000 and 
Občasni (³ 1/1000 in
In order to minimise the potential of developing postural hypotension in patients receiving alpha-blocker treatment, patients should be stabilised on alpha-blocker therapy prior to initiating sildenafil treatment. 
Da bi čim bolj zmanjšali možnost pojava posturalne hipotenzije pri bolnikih, ki se zdravijo z antagonisti adrenergičnih receptorjev alfa, morajo biti bolniki pred začetkom zdravljenja s sildenafilom stabilizirani na zdravljenju z antagonisti adrenergičnih receptorjev alfa.
This is most likely to occur within 4 hours post sildenafil dosing. 
Verjetnost tega je največja v 4 urah po uporabi sildenafila.
Sildenafil Actvis 25 mg, 50 mg and 100 mg film-coated tablets Sildenafil Actavis 25 mg film-coated tablets Sildenafil Actavis 50 mg film-coated tablets Sildenafil Actavis 100 mg film-coated tablets sildenafil 
Sildenafil Actvis 25 mg, 50 mg in 100 mg filmsko obložene tablete Sildenafil Actavis 25 mg filmsko obložene tablete Sildenafil Actavis 50 mg filmsko obložene tablete Sildenafil Actavis 100 mg filmsko obložene tablete sildenafil
When a single 100 mg dose of sildenafil was administered with erythromycin, a moderate CYP3A4 inhibitor, at steady state (500 mg twice daily for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC). 
Uporaba enega 100 mg odmerka sildenafila hkrati z zmernim zaviralcem CYP3A4 eritromicinom v stanju dinamičnega ravnovesja (500 mg dvakrat na dan 5 dni) je povzročila 182% povečanje sistemske izpostavljenosti (AUC) sildenafilu.
Rare (may affect up to 1 in 1,000 people): fainting, stroke, heart attack, irregular heartbeat, temporary decreased blood flow to parts of the brain, feeling of tightening of the throat, numb mouth, bleeding at the back of the eye, double vision, reduced sharpness of vision, abnormal sensation in the eye, swelling of the eye or eyelid, small particles or spots in your vision, seeing halos around lights, dilation of the pupil of the eye, discolouration of the white of the eye, penile bleeding, presence of blood in semen, dry nose, swelling of the inside of the nose, feeling irritable and sudden decrease or loss of hearing. 
Redki (pojavijo se lahko pri največ 1 od 1000 bolnikov) so omedlevica, kap, srčni napad, neenakomeren srčni utrip, prehodno zmanjšanje pretoka krvi skozi dele možganov, občutek zategovanja v grlu, omrtvelost ust, krvavitev v ozadju očesa, dvojni vid, zmanjšana ostrina vida, nenormalen občutek v očesu, oteklost očesa ali veke, drobni delci ali pike v vidnem polju, videnje svetlobnih krogov okoli luči, razširitev očesne zenice, obarvanje očesne beločnice, krvavitev iz penisa, prisotnost krvi v spermi, suh nos, oteklost notranjosti nosu, razdražljivost, nenadno zmanjšanje ali izguba sluha.
- Serious skin reactions - this occurs rarely Symptoms may include severe peeling and swelling of the skin, blistering of the mouth, genitals and around the eyes, fever. 
Simptomi lahko vključujejo hudo lupljenje in otekanje kože, mehurčke na ustih, spolovilu in okoli oči, vročino.
Indigo carmine aluminium lake (E132) 
indigotin (E132).
Uncommon (may affect up to 1 in 100 people): vomiting, skin rash, eye irritation, bloodshot eyes /red eyes, eye pain, seeing flashes of light, visual brightness, light sensitivity, watery eyes, pounding heartbeat, rapid heartbeat, high blood pressure, low blood pressure, muscle pain, feeling sleepy, reduced sense of touch, vertigo, ringing in the ears, dry mouth, blocked or stuffy sinuses, inflammation of the lining of the nose (symptoms include runny nose, sneezing and stuffy nose), upper abdominal pain, gastro-oesophageal reflux disease (symptoms include heartburn), presence of blood in urine, pain in the arms or legs, nosebleed, feeling hot and feeling tired. 
Občasni (pojavijo se lahko pri največ 1 od 100 bolnikov) so bruhanje, izpuščaj na koži, draženje oči, krvave/rdeče oči, bolečine v očeh, svetlobni bliski, občutek svetlosti pri gledanju, občutljivost na svetlobo, solzne oči, razbijanje srca, zvišan srčni utrip, visok krvni tlak, nizek krvni tlak, bolečine v mišicah, zaspanost, zmanjšana občutljivost na dotik, vrtoglavica, zvenenje v ušesih, , suha usta, zamašeni sinusi (obnosne votline), vnetje sluznice nosu (vključno z izcedkom iz nosu, kihanjem in zamašenim nosom), bolečina v zgornjem delu trebuha, gastroezofagealna refluksna bolezen (simptomi vključujejo zgago), prisotnost krvi v urinu, bolečine v rokah ali nogah, krvavitev iz nosu, občutek vročine in utrujenost.
Sildenafil Actavis 100 mg film-coated tablets EU/1/09/595/011 
Sildenafil Actavis 100 mg filmsko obložene tablete EU/1/09/595/011
Sildenafil is cleared predominantly by the CYP3A4 (major route) and CYP2C9 (minor route) hepatic microsomal isoenzymes. 
Sildenafil se odstrani predvsem prek jetrnih mikrosomskih izoencimov CYP3A4 (glavna pot) in CYP2C9 (manj pomembna pot).
In order to minimise the potential for developing postural hypotension, patients should be hemodynamically stable on alpha-blocker therapy prior to initiating sildenafil treatment. 
Da bi čim bolj zmanjšali možnost za pojav posturalne hipotenzije, morajo biti bolniki pred začetkom zdravljenja s sildenafilom hemodinamsko stabilizirani na zdravljenju z antagonisti adrenergičnih receptorjev alfa.
However, you may find that Sildenafil Actavis takes longer to start working if you take it with a heavy meal. 
Toda če zdravilo Sildenafil Actavis vzamete s težjim obrokom, lahko traja dlje, preden začne delovati.
The N-desmethyl metabolite is further metabolised, with a terminal half-life of approximately 4 h. 
Njegov terminalni razpolovni čas je približno 4 ure.
Always take this medicine exactly as your doctor or pharmacist has told you. 
Pri jemanju tega zdravila natančno upoštevajte navodila svojega zdravnikova ali farmacevta.
Mild and transient differences in colour discrimination (blue/green) were detected in some subjects using the Farnsworth-Munsell 100 hue test at 1 hour following a 100 mg dose, with no effects evident after 2 hours post-dose. 
Pri nekaterih preiskovancih so s Farnsworth-Munsellovim testom s 100 barvnimi odtenki 1 uro po odmerku 100 mg ugotovili blage in prehodne spremembe razločevanja barv (modra/zelena), 2 uri po odmerku pa teh učinkov ni bilo več.
Healthy, elderly volunteers (65 years or over) had a reduced clearance of sildenafil, resulting in approximately 90% higher plasma concentrations of sildenafil and the active N-desmethyl metabolite compared to those seen in healthy younger volunteers (18-45 years). 
Koncentracija sildenafila in njegovega aktivnega N-dezmetilnega presnovka v plazmi je bila tako približno 90% večja kot pri mlajših zdravih prostovoljcih (starih od 18 do 45 let).
Sildenafil Actavis 25 mg film-coated tablets EU/1/09/595/001 
Sildenafil Actavis 25 mg filmsko obložene tablete EU/1/09/595/001
Each tablet contains sildenafil citrate equivalent to 25, 50 or 100 mg of sildenafil. 
KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena tableta vsebuje sildenafil citrat, ki ustreza 25, 50 ali 100 mg sildenafila.
What Sildenafil Actavis looks like and contents of the pack 
Izgled zdravila Sildenafil Actavis in vsebina pakiranja
To reduce the chance that these symptoms might happen, you should be on a regular daily dose of your alpha-blocker before you start Sildenafil Actavis. 
Da bi zmanjšali verjetnost za pojav teh simptomov, morate pred začetkom uporabe zdravila Sildenafil Actavis uporabljati stalen dnevni odmerek antagonista adrenergičnih receptorjev alfa.
Sildenafil Actavis 50 mg film-coated tablets EU/1/09/595/006 
Sildenafil Actavis 50 mg filmsko obložene tablete EU/1/09/595/006
EU/1/09/595/011 [1 film-coated tablet] EU/1/09/595/012 [2 film-coated tablets] EU/1/09/595/013 [4 film-coated tablets] EU/1/09/595/014 [8 film-coated tablets] EU/1/09/595/015 [12 film-coated tablets] EU/1/09/595/018 [24 film-coated tablets] 
EU/1/09/595/011 [1 filmsko obložena tableta] EU/1/09/595/012 [2 filmsko obloženi tableti] EU/1/09/595/013 [4 obložene tablete] EU/1/09/595/014 [8 obloženih tablet] EU/1/09/595/015 [12 obloženih tablet] EU/1/09/595/018 [24 obloženih tablet]
Myocardial infarction, Ventricular arrhythmia, Atrial fibrillation, Unstable angina 
Srčne bolezni tahikardija, palpitacije nenadna srčna smrt,* miokardni infarkt, ventrikularna aritmija,* atrijska fibrilacija, nestabilna angina pektoris
You should not take Sildenafil Actavis if you are using any of the medicines known as nitric oxide donors such as amyl nitrite (“poppers”) as the combination may also lead to a dangerous fall in your blood pressure. 
Zdravila Sildenafil Actavis ne smete jemati, če uporabljate kakšne snovi, znane kot "dajalci dušikovega oksida", npr. amilnitrit (imenovan tudi "poppers").
The total body clearance of sildenafil is 41 L/h with a resultant terminal phase half-life of 3-5 h. After either oral or intravenous administration, sildenafil is excreted as metabolites predominantly in the faeces (approximately 80% of administered oral dose) and to a lesser extent in the urine (approximately 13% of administered oral dose). 
Sildenafil se po peroralni in intravenski uporabi izloči v obliki presnovkov, pretežno v blatu (približno 80% peroralnega odmerka) in v manjši meri v urinu (približno 13% peroralnega odmerka).
With the exception of ritonavir for which co-administration with sildenafil is not advised (see section 4.4) a starting dose of 25 mg should be considered in patients receiving concomitant treatment with CYP3A4 inhibitors (see section 4.5). 
Za bolnike, ki sočasno dobivajo zaviralce CYP3A4, je priporočeni začetni odmerek 25 mg (glejte poglavje 4.5); izjema je ritonavir, ki ga ni priporočljivo uporabljati hkrati s sildenafilom (glejte poglavje 4.4).
Co-administration of the HIV protease inhibitor saquinavir, a CYP3A4 inhibitor, at steady state (1200 mg three times a day) with sildenafil (100 mg single dose) resulted in a 140% increase in sildenafil Cmax and a 210% increase in sildenafil AUC. 
Sočasna uporaba zaviralca proteaz HIV sakvinavirja, ki zavira CYP3A4, v stanju dinamičnega ravnovesja (1200 mg trikrat na dan) in sildenafila (posamičen odmerek 100 mg) je povzročila 140% povečanje Cmaks sildenafila in 210% povečanje njegove AUC.
EU/1/09/595/001 [1 film-coated tablet] EU/1/09/595/002 [2 film-coated tablets] EU/1/09/595/003 [4 film-coated tablets] EU/1/09/595/004 [8 film-coated tablets] EU/1/09/595/005 [12 film-coated tablets] EU/1/09/595/016 [24 film-coated tablets] 
EU/1/09/595/001 [1 filmsko obložena tableta] EU/1/09/595/002 [2 filmsko obloženi tableti] EU/1/09/595/003 [4 filmsko obložene tablete] EU/1/09/595/004 [8 filmsko obloženih tablet] EU/1/09/595/005 [12 filmsko obloženih tablet] EU/1/09/595/016 [24 filmsko obloženih tablet]
Serious cardiovascular events, including myocardial infarction, unstable angina, sudden cardiac death, ventricular arrhythmia, cerebrovascular haemorrhage, transient ischaemic attack, hypertension and hypotension have been reported post-marketing in temporal association with the use of sildenafil. 
V postmarketinškem obdobju so bili v časovni povezanosti z uporabo sildenafila opisani resni kardiovaskularni dogodki, med drugim miokardni infarkt, nestabilna angina pektoris, nenadna srčna smrt, ventrikularna aritmija, cerebrovaskularna krvavitev, tranzitorna ishemična ataka, hipertenzija in hipotenzija.
Sildenafil metabolism is principally mediated by the cytochrome P450 (CYP) isoforms 3A4 (major route) and 2C9 (minor route). 
Presnova sildenafila v glavnem poteka z izooblikama 3A4 (glavna pot) in 2C9 (manj pomembna pot) citokroma P450 (CYP).
In three specific drug-drug interaction studies, the alpha-blocker doxazosin (4 mg and 8 mg) and sildenafil (25 mg, 50 mg, or 100 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy. 
V treh specifičnih študijah medsebojnega delovanja zdravil so bolnikom z benigno prostatično hiperplazijo (BPH), stabiliziranih na zdravljenju z doksazosinom, sočasno dali antagonist adrenergičnih receptorjev alfa doksazosin (4 mg in 8 mg) in sildenafil (25 mg, 50 mg ali 100 mg).
EU/1/09/595/006 [1 film-coated tablet] EU/1/09/595/007 [2 film-coated tablets] EU/1/09/595/008 [4 film-coated tablets] EU/1/09/595/009 [8 film-coated tablets] EU/1/09/595/010 [12 film-coated tablets] EU/1/09/595/017 [24 film-coated tablets] 
EU/1/09/595/006 [1 filmsko obložena tableta] EU/1/09/595/007 [2 filmsko obloženi tableti] EU/1/09/595/008 [4 obložene tablete] EU/1/09/595/009 [8 obloženih tablet] EU/1/09/595/010 [12 obloženih tablet] EU/1/09/595/017 [24 obloženih tablet]
In addition, N-desmethyl metabolite AUC and Cmax values were significantly increased 79% and 200% respectively. 
Poleg tega sta se pomembno zvečali tudi AUC (za 79%) in Cmaks (za 200%) N-dezmetilnega presnovka.
Sildenafil Actavis 100 mg tablets Each tablet contains 249.52 mg lactose (as monohydrate). 
Ena tableta vsebuje 249.52 mg laktoze (v obliki monohidrata).
Common (may affect up to 1 in 10 people): nausea, facial flushing, hot flush (symptoms include a sudden feeling of heat in your upper body), indigestion, colour tinge to vision, blurred vision, visual disturbance, stuffy nose and dizziness. 
Pogosti (pojavijo se lahko pri največ 1 od 10 bolnikov) so slabost s siljenjem na bruhanje, zardevanje obraza, vročinski oblivi (nenaden občutek vročine v zgornjem delu telesa), prebavne težave, spremenjeno zaznavanje barv, zamegljen vid, motnje vida, zamašenost nosu in omotica.
There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil in healthy volunteers (see section 4.6). 
Pri zdravih prostovoljcih enkraten peroralni odmerek 100 mg sildenafila ni vplival na gibljivost ali morfologijo semenčic (glejte poglavje 4.6).
croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide (E171), 
- Pomožne snovi so laktoza monohidrat, mikrokristalna celuloza, povidon K29-32, premreženi natrijev karmelozat, magnezijev stearat, hipromeloza, titanov dioksid (E171), makrogol 6000,
Each tablet contains 25 mg, 50 mg or 100 mg of sildenafil (as citrate). 
Ena tableta vsebuje 25 mg, 50 mg ali 100 mg sildenafila (kot citrata) - Zdravilna učinkovina je sildenafil.
Reproductive system and breast disorders 
Infekcijske in parazitske bolezni rinitis
Sildenafil Actavis 50 mg tablets Each tablet contains 124.76 mg lactose (as monohydrate). 
Ena tableta vsebuje 124.76 mg laktoze (v obliki monohidrata).